Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reissue Patent
2006-09-05
2006-09-05
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S253100, C514S254040, C514S254060, C514S217000, C514S233800, C514S234500, C514S249000, C514S258100, C514S269000, C514S274000, C514S296000, C514S300000, C514S301000, C514S307000, C514S309000, C514S311000, C514S312000, C514S314000, C514S321000, C514S322000, C514S373000, C514S379000, C514S403000, C514S411000, C540S576000, C540S588000, C544S121000, C544S129000, C544S132000, C544S135000, C544S137000, C544S279000, C544S295000, C544S316000, C544S317000, C544S318000, C544S333000, C544S353000, C544S361000, C544S
Reissue Patent
active
RE039265
ABSTRACT:
Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses by administering to a mammal a psychoses-treating effective amount of one of the compounds. The compounds are also useful as analgesics by administering a pain-relieving effective amount of one of the compounds to a mammal.
REFERENCES:
patent: 3950527 (1976-04-01), Derible et al.
patent: 4355037 (1982-10-01), Strupczewski et al.
patent: 4458076 (1984-07-01), Strupczewski
patent: 4590196 (1986-05-01), Smith et al.
patent: 4670447 (1987-06-01), Strupczewski et al.
patent: 4745117 (1988-05-01), Ishizumi
patent: 4780466 (1988-10-01), Hrib et al.
patent: 4880930 (1989-11-01), New
patent: 4937249 (1990-06-01), Antoku et al.
patent: 4954503 (1990-09-01), Strupczewski
patent: 4968792 (1990-11-01), Stack et al.
patent: 4999356 (1991-03-01), Strupczewski et al.
patent: 5001134 (1991-03-01), Ferrand et al.
patent: 5364866 (1994-11-01), Strupczewski et al.
patent: 353 0089 (1986-03-01), None
patent: 2 503 816 (1975-07-01), None
patent: 0 261 688 (1980-03-01), None
patent: 0 013 612 (1980-07-01), None
patent: 0 135 781 (1985-04-01), None
patent: 0 196 096 (1986-10-01), None
patent: 0 302 423 (1989-02-01), None
patent: 0 314 098 (1989-05-01), None
patent: 0 329 168 (1989-08-01), None
patent: 0 353 821 (1990-02-01), None
patent: 0 357 134 (1990-03-01), None
patent: 0 398 425 (1990-11-01), None
patent: 0 402 644 (1990-12-01), None
patent: 0 464 846 (1992-01-01), None
patent: 0 542 136 (1993-05-01), None
patent: 2 163 432 (1986-02-01), None
patent: 233 710 (1990-05-01), None
patent: 233 503 (1991-06-01), None
patent: 233 525 (1991-09-01), None
patent: WO93/09012 (1993-05-01), None
patent: WO 93/16073 (1993-08-01), None
patent: WO94/18196 (1994-08-01), None
Fuller, R.W., Drugs Acting on Serotonergie Neuronal Systems, Biology of Serotonergic Transmission, John Wiley & Sons Ltd., 1982, pp. 221-247.
Bordeau Kenneth J.
Chiang Yulin
Glamkowski Edward J.
Helsley Grover C.
Strupczewski Joseph T.
Aventis Pharmaceuticals Inc.
Coleman Brenda
Synnestvedt & Lechner LLP
LandOfFree
Heteroarylpiperidines, and their use as antipsychotics and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroarylpiperidines, and their use as antipsychotics and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylpiperidines, and their use as antipsychotics and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3536422